Xarelto Class Action Lawsuits
Bellwether Trials in the Xarelto MDL is Set to Begin This Spring
A judge, Eldon E Fallon of the U.S. District Court in Louisiana has moved the date for the long-awaited bellwether trials ahead to April 2017. Initially, the trial date had been set to begin in February but due to a conflict of scheduled events, the trial start date had to be pushed to April.
The Xarelto bellwether trials will serve to help the attorneys and judges involved in the now massive number of case to determine how the following cases may go. Over the past few years, claims against Johnson & Johnson and Bayer, the massive healthcare companies and the makers have begun to stack up. Now it is estimated that the number of lawsuits against the healthcare juggernauts has grown to around 10,000.
Risk of Bleeding
Originally approved for its introduction into the market by the FDA in 2012 it fast became one of the top-selling drugs on the market. Soon, however, it became apparent the drug was problematic as thousands of reports started surfacing regarding the drug’s deadly side effects. After less than a year, 2,000 reports were made including 151 deaths. In 2014, the FDA released a warning that Xarelto may cause uncontrollable hemorrhaging. The warning also stated that there was no known antidote to stop the bleeding once it started.
The Bellwether Trials and the MDL
In December of 2014, MDL 2592 was established by Lawyers in the Eastern District of Louisiana by the U.S. Judicial Panel on Multidistrict Litigation. On January 29, 2015, the first Xarelto MDL pretrial conference was held by Judge Fallon. After much preparation, the first case is set for trial in April 2017.
The Eastern District of Louisiana will host the first two Bellwether trials which are set for April 24, 2017, which is the Joseph Boudreaux case, and the Joseph Orr case which is set for May 30, 2017. The next two Bellwether trials will be conducted in the Southern District of Mississippi in June 2017 and in the North District of Texas in July 2017.
The Boudreaux case was filed in December 2014. The plaintiff, in this case, claims that he was prescribed for his atrial fibrillation in order to reduce the risk of stroke. However, within a month of taking it, Mr. Boudreaux suffered from a severe and life-threatening gastrointestinal bleed. The plaintiff was hospitalized and received several blood transfusions.
In the Orr case, the plaintiff and her Lawyers allege that his wife, Sharon began taking Rivaroxaban in May 2015 for atrial fibrillation. It is alleged that within one month of her using Rivaroxaban she developed a brain hemorrhage and died after being hospitalized and suffering for 10 days from the bleed.
Plaintiffs in these cases are alleging that the company failed to provide patients with an adequate warning as to the severity of side effects that can accompany taking the drug. They are also claiming that the company fraudulently claimed the drug was safer than other drugs that are used for the same conditions through false advertising. It is alleged that the company also did not make consumers aware of the fact that there is not an antidote to treat the most severe and deadly side effect of Xarelto which is internal bleeding. In addition, it is alleged physicians were encouraged to prescribe the medication without proper knowledge of the severity of the risks of life-threatening side effects.
Xarelto is prescribed to those who have an increased risk of blood clots primarily in patients who suffer from atrial fibrillation. The drug acts as a blood thinner to prevent or treat types of blood clots called deep vein thrombosis or pulmonary embolus. It is an anticoagulant that works by blocking certain proteins in the blood that contribute to clotting.
If you or someone you know has suffered life-threatening side effects or death you may be entitled to receive compensation for your suffering. If you have suffered from any side effects or health complications from the use of Xarelto, we can help you.
There are about 2,000 class action cases involved in the Xarelto Settlements, but it is expected that several thousand additional cases will be filed over the next year or two. The number of lawsuits is expected to grow however due to the fact that as more and more people take the drug, there is an increase in the amount of people with adverse side effects.
Lawsuit #1: Betty Samson
Canadian resident Betty Samson was taking the drug in September of 2012 and fell into cardiac arrest shortly after. She alleges that doctors were “unable to quickly stabilize the internal bleeding allegedly linked to her use.” Samson also states that, “the health care professionals treating her had extreme difficulty in stopping her bleeding.”
According to her complaint, Health Canada has received at least 1,100 documented cases of adverse side effects. In her Xarelto class action lawsuit, She includes in her complaint reports from Germany that linked to 130 deaths between 2012 and 2013.
Lawsuit #2: Virginia Stunteneck
Virginia Stunteneck, a resident of Kentucky, filed a similar blood clot lawsuit against medical giant Bayer stating that she was hospitalized after she took Xarelto and was affected by severe gastrointestinal bleeding in 2013.
According to Stuteneck, the drug manufacturers knew their medicine came with serious side effects but chose to manufacture it anyway. Stuteneck’s lawyers in the Bayer lawsuit state that the drug conglomerate remained silent about the possibly deadly side effects despite the mounting evidence against the drug.
Lawsuit #3 : Margaret Garvy
In another recent lawsuit filed by Margaret Garvy, she alleges the side effects caused her to suffer bleeding complications. In court, Garvy states she only took the drug for less than two weeks during May of 2014 and was soon diagnosed with hemorrhagic pericardial effusion, pericardial tamponade and pleural effusion.
These conditions indicate bleeding around the heart and lungs and were reportedly linked to her Xarelto use.
Xarelto Class Action Lawsuits
Before taking Xarelto consult with a medical professional. The litigation mentioned on this page are not reflective of every case, so prior to taking any need medications you should always seek the advice of your doctor or a specialist. For more information about Xarelto Class Action Lawsuits please continue to our Medical Information Page.
Damaging Evidence Exposed
Within months of the drug hitting the market in 2011, severe and deadly side effects began to surface. This spurred a high number of injury and wrongful death lawsuits against the makers of Rivaroxaban. Plaintiffs in these cases are alleging that the company failed to provide patients with an adequate warning as to the severity of side effects that can accompany taking the drug. They are also claiming that the company fraudulently claimed the drug was safer than other drugs that are used for the same conditions through false advertising. It is alleged that the company also did not make consumers aware of the fact that there is not an antidote to treat the most severe and deadly side effect of Xarelto which is internal bleeding. In addition, it is alleged physicians were encouraged to prescribe the medication without proper knowledge of the severity of the risks of life-threatening side effects.
Cases Against Rivaroxaban
Thomas Dunkley also suffered from AFib. He was also prescribed Xarelto for his issue by his physician. Within mere days of starting the drug, he began to experience severe headaches. Two weeks after starting, Mr. Dunkley died from a subdural hemorrhage.
These stories have become commonplace among plaintiffs who are seeking justice against Bayer and Johnson & Johnson, the makers. Xarelto had been advertised as a safer and less obtrusive alternative to its competitors such as Warfarin. However, it quickly became apparent that Xarelto’s issues were extremely deadly. Unfortunately, the makers appear to have been negligent in the making and marketing of the drug and failed to make the public aware its dangers or disengage their high-profile ad campaign.
Claims and Allegations
- Bayer and Johnson & Johnson intentionally withheld the fact that Xarelto increased the risk for deadly hemorrhaging.
- The makers intentionally withheld the fact that there is no active antidote for the bleeding issues Xarelto can cause.
- The makers misled patients and physicians through false claims in a high-profile and aggressive ad campaign.
- The makers funded studies that have been shown to have produced skewed results that led many to believe Xarelto was safe.
- The makers intentionally concealed evidence of the dangers of Xarelto from the public and the FDA.
- The makers were negligent in the manufacturing of Xarelto.
Xarelto is an anticoagulant that prevents the formation of deep vein thrombosis blood clots. Deep vein thrombosis can cause blood clots in the lungs, and can occur after certain types of surgery. The drug was approved in 2011, and is one of the most recent blood thinners to enter the market.
Bayer and Johnson & Johnson‘s Janssen Pharmaceuticals are facing many Xarelto class action lawsuits, with plaintiffs claiming that the drug is dangerous to human consumption and has many side effects.
Complainants in the blood thinner lawsuit allege serious and possibly fatal side effects such as; severe internal bleeding, cerebral hemorrhaging, brain hemorrhages, and gastrointestinal bleeds. Plaintiffs claim that, unlike other popular anticoagulants there is no antidote available for Xarelto.